Academic Researchers Escape Scrutiny in Glaxo Fraud Settlement

Toby Melville, Reuters, Newscom

A building in London bears the GlaxoSmithKline logo. A 2007 BBC documentary explored the fraud accusations that led to the recent U.S. settlement, in which the British company has agreed to pay $3-billion.
August 06, 2012

Federal prosecutors triumphantly announced the nation's largest-ever health-care-fraud settlement last month, when the pharmaceutical maker GlaxoSmithKline admitted marketing its drugs for unapproved purposes.

Virtually unpublicized was a key detail…

This content is available exclusively to Chronicle subscribers